GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » Net Income Including Noncontrolling Interests

Shanghai Serum Bio Technology Co (SHSE:688163) Net Income Including Noncontrolling Interests : ¥37.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Serum Bio Technology Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Shanghai Serum Bio Technology Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥1.5 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥37.2 Mil.


Shanghai Serum Bio Technology Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Shanghai Serum Bio Technology Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Serum Bio Technology Co Net Income Including Noncontrolling Interests Chart

Shanghai Serum Bio Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.76 63.17 76.48 64.20 38.77

Shanghai Serum Bio Technology Co Quarterly Data
Dec16 Dec17 Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 23.89 23.89 -12.02 1.48

Shanghai Serum Bio Technology Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥37.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Serum Bio Technology Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Shanghai Serum Bio Technology Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Serum Bio Technology Co (SHSE:688163) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 1288, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Shanghai Serum Bio Technology Co Ltd is engaged in the research, development, production and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety.

Shanghai Serum Bio Technology Co (SHSE:688163) Headlines

No Headlines